Niger vs Papua New Guinea: Survival to age 65, male
Niger
60.5%
in 2024
Papua New Guinea
59.8%
in 2024
Niger rank
184th
Papua New Guinea rank
187th
Survival to age 65, male over time
- Niger
- Papua New Guinea
How they compare
Niger currently reports 60.5% against 59.8% in Papua New Guinea, a difference of 0.7%.
The two have swapped places 1 time across 65 shared years of data; in 1960 it was Papua New Guinea ahead.
Niger ranks 184th and Papua New Guinea ranks 187th of 218 countries.
Across the 7 decades both report, Niger averaged higher in 1 and Papua New Guinea in 6.
Head to head by decade
| Decade | Niger | Papua New Guinea | Difference | Ahead |
|---|---|---|---|---|
| 1960s | 24.6% | 34.7% | 10.2% | Papua New Guinea |
| 1970s | 25.9% | 43.2% | 17.3% | Papua New Guinea |
| 1980s | 33.5% | 48.9% | 15.4% | Papua New Guinea |
| 1990s | 39.8% | 52.2% | 12.4% | Papua New Guinea |
| 2000s | 48.4% | 54.3% | 5.8% | Papua New Guinea |
| 2010s | 56.2% | 57.0% | 0.8% | Papua New Guinea |
| 2020s | 58.4% | 57.7% | 0.7% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher survival to age 65, male, Niger or Papua New Guinea?
- Niger, at 60.5% against 59.8% in Papua New Guinea as of 2024.
- What is the difference in survival to age 65, male between Niger and Papua New Guinea?
- 0.7%, with Niger ahead.
- How many years of comparable data are there for Niger and Papua New Guinea?
- 65 years are reported by both, from 1960 to 2024.
- How do Niger and Papua New Guinea rank globally for survival to age 65, male?
- Niger ranks 184th and Papua New Guinea ranks 187th of 218 countries.
- Where does this data come from?
- World Population Prospects, United Nations (UN), publisher: UN Population Division, published as Survival to age 65, male (% of cohort). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Survival to age 65 refers to the percentage of a cohort of newborn infants that would survive to age 65, if subject to age specific mortality rates of the specified year.